-
1
-
-
84855684309
-
Investigation of UDP-glucuronosyltransferases (UGTs) inhibitory properties of carvacrol
-
Dong RH, Fang ZZ, Zhu LL, Liang SC, Ge GB, Yang L, Liu ZY (2012) Investigation of UDP-glucuronosyltransferases (UGTs) inhibitory properties of carvacrol. Phytother Res 26: 86-90.
-
(2012)
Phytother Res
, vol.26
, pp. 86-90
-
-
Dong, R.H.1
Fang, Z.Z.2
Zhu, L.L.3
Liang, S.C.4
Ge, G.B.5
Yang, L.6
Liu, Z.Y.7
-
2
-
-
75149152466
-
Time-dependent inhibition (TDI) of CYP3A4 and CYP2C9 by noscapine potentially explains clinical noscapine-warfarin interaction
-
Fang ZZ, Zhang YY, Ge GB, Huo H, Liang SC, Yang L (2010) Time-dependent inhibition (TDI) of CYP3A4 and CYP2C9 by noscapine potentially explains clinical noscapine-warfarin interaction. Br J Clin Pharmacol 69: 193-199.
-
(2010)
Br J Clin Pharmacol
, vol.69
, pp. 193-199
-
-
Fang, Z.Z.1
Zhang, Y.Y.2
Ge, G.B.3
Huo, H.4
Liang, S.C.5
Yang, L.6
-
3
-
-
79551670426
-
Identification of cytochrome P450 (CYP) isoforms involved in the metabolism of corynoline, and assessment of its herb-drug interactions
-
Fang ZZ, Zhang YY, Ge GB, Liang SC, Sun DX, Zhu LL, Dong PP, Cao YF, Yang L (2011) Identification of cytochrome P450 (CYP) isoforms involved in the metabolism of corynoline, and assessment of its herb-drug interactions. Phytother Res 25: 256-263.
-
(2011)
Phytother Res
, vol.25
, pp. 256-263
-
-
Fang, Z.Z.1
Zhang, Y.Y.2
Ge, G.B.3
Liang, S.C.4
Sun, D.X.5
Zhu, L.L.6
Dong, P.P.7
Cao, Y.F.8
Yang, L.9
-
4
-
-
0028031001
-
Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates
-
Green MD, Oturu EM, Tephly TR (1994) Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates. Drug Metab Dispos 22: 799-805. (Pubitemid 24307496)
-
(1994)
Drug Metabolism and Disposition
, vol.22
, Issue.5
, pp. 799-805
-
-
Green, M.D.1
Oturu, E.M.2
Tephly, T.R.3
-
5
-
-
10844292763
-
Immunosuppressive drugs for kidney transplantation
-
Halloran PF (2004) Immunosuppressive drugs for kidney transplantation. N Eng J Med 351: 2715-2729.
-
(2004)
N Eng J Med
, vol.351
, pp. 2715-2729
-
-
Halloran, P.F.1
-
6
-
-
34249937715
-
Morphine glucuronosyltransferase activity in human liver microsomes is inhibited by a variety of drugs that are co-administered with morphine
-
Hara Y, Nakajima M, Miyamoto K, Yokoi T (2007) Morphine glucuronosyltransferase activity in human liver microsomes is inhibited by a variety of drugs that are co-administered with morphine. Drug Metab Pharmacokinet 22: 103-112.
-
(2007)
Drug Metab Pharmacokinet
, vol.22
, pp. 103-112
-
-
Hara, Y.1
Nakajima, M.2
Miyamoto, K.3
Yokoi, T.4
-
7
-
-
43749101127
-
Interaction between tacrolimus and lansoprazole, but not rabeprazole in living-donor liver transplant patients with defects of CYP2C19 and CYP3A5
-
Hosohata K, Masuda S, Ogura Y, Oike F, Takada Y, Katsura T, Uemoto S, Inui K (2008) Interaction between tacrolimus and lansoprazole, but not rabeprazole in living-donor liver transplant patients with defects of CYP2C19 and CYP3A5. Drug Metab Pharmacokinet 23: 134-138.
-
(2008)
Drug Metab Pharmacokinet
, vol.23
, pp. 134-138
-
-
Hosohata, K.1
Masuda, S.2
Ogura, Y.3
Oike, F.4
Takada, Y.5
Katsura, T.6
Uemoto, S.7
Inui, K.8
-
8
-
-
78650281301
-
Strong inhibitory effect of medroxyprogesterone acetate (MPA) on UDP-glucuronosyltransferase (UGT) 2B7 might induce drug-drug interactions
-
Huang T, Fang ZZ, Yang L (2010) Strong inhibitory effect of medroxyprogesterone acetate (MPA) on UDP-glucuronosyltransferase (UGT) 2B7 might induce drug-drug interactions. Pharmazie 65: 919-921.
-
(2010)
Pharmazie
, vol.65
, pp. 919-921
-
-
Huang, T.1
Fang, Z.Z.2
Yang, L.3
-
9
-
-
79957472949
-
Inhibitory potential of chlormadinone acetate (CMA) on five important UDP-glucuronosyltransferases in human liver
-
Huang T, Fang ZZ, Zhang YY, Zhu LL, Feng LL, Zheng W, Cao YF, Sun DX, Yang L (2011) Inhibitory potential of chlormadinone acetate (CMA) on five important UDP-glucuronosyltransferases in human liver. Pharmazie 66: 212-215.
-
(2011)
Pharmazie
, vol.66
, pp. 212-215
-
-
Huang, T.1
Fang, Z.Z.2
Zhang, Y.Y.3
Zhu, L.L.4
Feng, L.L.5
Zheng, W.6
Cao, Y.F.7
Sun, D.X.8
Yang, L.9
-
10
-
-
0025996996
-
Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11
-
Kawato Y, Aonuma M, Hirota Y, Kuga H, Sato K (1991) Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11. Cancer Res 51: 4187-4191.
-
(1991)
Cancer Res
, vol.51
, pp. 4187-4191
-
-
Kawato, Y.1
Aonuma, M.2
Hirota, Y.3
Kuga, H.4
Sato, K.5
-
11
-
-
15244342411
-
UDP-glucuronosyltransferases and clinical drug-drug interactions
-
DOI 10.1016/j.pharmthera.2004.10.013
-
Kiang TK, Ensom MH, Chang TK (2005) UDP-glucuronosyltransferases and clinical drug-drug interactions. Pharmacol Ther 106: 97-132. (Pubitemid 40386722)
-
(2005)
Pharmacology and Therapeutics
, vol.106
, Issue.1
, pp. 97-132
-
-
Kiang, T.K.L.1
Ensom, M.H.H.2
Chang, T.K.H.3
-
12
-
-
77953783039
-
Spironolactone and canrenone inhibit UGT2B7-catalyzed human liver and kidney microsomal aldosterone 18β-glucuronidation: A potential drug interaction
-
Knights KM, Bowalgaha K, Miners JO. (2010) Spironolactone and canrenone inhibit UGT2B7-catalyzed human liver and kidney microsomal aldosterone 18β-glucuronidation: A potential drug interaction. Drug Metab Disp 36: 1056-1062.
-
(2010)
Drug Metab Disp
, vol.36
, pp. 1056-1062
-
-
Knights, K.M.1
Bowalgaha, K.2
Miners, J.O.3
-
13
-
-
79959453365
-
In vitro investigation of human UDP-glucuronosyltransferase isoforms responsible for tacrolimus glucuronidation: Predominant contribution of UGT1A4
-
Laverdiere I, Caron P, Harvey M, Lévesque É, Guillemette C (2011) In vitro investigation of human UDP-glucuronosyltransferase isoforms responsible for tacrolimus glucuronidation: predominant contribution of UGT1A4. Drug Metab Dispos 39: 1127-1130.
-
(2011)
Drug Metab Dispos
, vol.39
, pp. 1127-1130
-
-
Laverdiere, I.1
Caron, P.2
Harvey, M.3
Lévesque, É.4
Guillemette, C.5
-
14
-
-
0027960058
-
Pharmacokinetic interaction between zidovudine and valproic acid in patients infected with human immunodeficiency virus
-
Lertora JJ, Rege AB, Greenspan DL, Akula S, George WJ, Hyslop NE Jr, Agrawal KC (1994) Pharmacokinetic interaction between zidovudine and valproic acid in patients infected with human immunodeficiency virus. Clin Pharmacol Ther 56: 272-278. (Pubitemid 24323918)
-
(1994)
Clinical Pharmacology and Therapeutics
, vol.56
, Issue.3
, pp. 272-278
-
-
Lertora, J.J.L.1
Rege, A.B.2
Greenspan, D.L.3
Akula, S.4
George, W.J.5
Hyslop Jr., N.E.6
Agrawal, K.C.7
-
15
-
-
0031472588
-
Role of pharmacokinetics and metabolism in drug discovery and development
-
Lin JH, Lu AYH (1997) Role of pharmacokinetics and metabolism in drug discovery and development. Pharmacol Rev 49: 403-449. (Pubitemid 28030947)
-
(1997)
Pharmacological Reviews
, vol.49
, Issue.4
, pp. 403-449
-
-
Lin, J.H.1
Lu, A.Y.H.2
-
16
-
-
0031975185
-
Update: Clinically significant cytochrome P450 drug interactions
-
Michalets EL (1998) Update: clinically significant cytochrome P450 drug interactions. Pharmacotherapy 18: 84-112.
-
(1998)
Pharmacotherapy
, vol.18
, pp. 84-112
-
-
Michalets, E.L.1
-
17
-
-
0027931806
-
Effect of fluconazole on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus
-
Sahai J, Gallicano K, Pakuts A, Cameron DW (1994) Effect of fluconazole on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus. J Infect Dis 169: 1103-1107. (Pubitemid 24303236)
-
(1994)
Journal of Infectious Diseases
, vol.169
, Issue.5
, pp. 1103-1107
-
-
Sahai, J.1
Gallicano, K.2
Pakuts, A.3
Cameron, D.W.4
-
18
-
-
77955646498
-
Inhibitory effects of curcumenol on human liver cytochrome P450 enzymes
-
Sun DX, Fang ZZ, Zhang YY, Cao YF, Yang L, Yin J (2010a) Inhibitory effects of curcumenol on human liver cytochrome P450 enzymes. Phytother Res 24: 1213-1216.
-
(2010)
Phytother Res
, vol.24
, pp. 1213-1216
-
-
Sun, D.X.1
Fang, Z.Z.2
Zhang, Y.Y.3
Cao, Y.F.4
Yang, L.5
Yin, J.6
-
19
-
-
78049420487
-
Reversible inhibition of three important human liver cytochrome P450 enzymes by tiliroside
-
Sun DX, Lu JC, Fang ZZ, Zhang YY, Cao YF, Mao YX, Zhu LL, Yin J, Yang L (2010b) Reversible inhibition of three important human liver cytochrome P450 enzymes by tiliroside. Phytother Res 24: 1670-1675.
-
(2010)
Phytother Res
, vol.24
, pp. 1670-1675
-
-
Sun, D.X.1
Lu, J.C.2
Fang, Z.Z.3
Zhang, Y.Y.4
Cao, Y.F.5
Mao, Y.X.6
Zhu, L.L.7
Yin, J.8
Yang, L.9
-
20
-
-
0032456884
-
Clinically important pharmacokinetic drug-drug interactions: Role of cytochrome P450 enzymes
-
Tanaka E (1998) Clinically important pharmacokinetic drug-drug interactions: role of cytochrome P450 enzymes. J Clin Pharm Ther 23: 403-416.
-
(1998)
J Clin Pharm Ther
, vol.23
, pp. 403-416
-
-
Tanaka, E.1
-
21
-
-
65349115890
-
Opportunities to optimize tacrolimus therapy in solid organ transplantation: Report of the European consensus conference
-
Wallemacq P, Armstrong VW, Brunet M, Haufroid V, Holt DW, Johnston A, Kuypers D, Le Meur Y, Marquet P, Oellerich M, Thervet E, Toenshoff B, Undre N, Weber LT, Westley IS, Mourad M (2009) Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference. Ther Drug Monit 31: 139-152.
-
(2009)
Ther Drug Monit
, vol.31
, pp. 139-152
-
-
Wallemacq, P.1
Armstrong, V.W.2
Brunet, M.3
Haufroid, V.4
Holt, D.W.5
Johnston, A.6
Kuypers, D.7
Le Meur, Y.8
Marquet, P.9
Oellerich, M.10
Thervet, E.11
Toenshoff, B.12
Undre, N.13
Weber, L.T.14
Westley, I.S.15
Mourad, M.16
-
22
-
-
33847358669
-
UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for etoposide glucuronidation in human liver and intestinal microsomes: Structural characterization of phenolic and alcoholic glucuronides of etoposide and estimation of enzyme kinetics
-
DOI 10.1124/dmd.106.012732
-
Wen Z, Tallman MN, Ali SY, Smith PC (2007) UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for etoposide glucuronidation in human liver and intestinal microsomes: structural characterization of phenolic and alcoholic glucuronides of etoposide and estimation of enzyme kinetics. Drug Metab Dispos 35: 371-380. (Pubitemid 46333899)
-
(2007)
Drug Metabolism and Disposition
, vol.35
, Issue.3
, pp. 371-380
-
-
Wen, Z.1
Tallman, M.N.2
Ali, S.Y.3
Smith, P.C.4
-
23
-
-
27544468948
-
In vitro inhibition of udp glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation
-
DOI 10.1124/dmd.105.005447
-
Zhang D, Chando TJ, Everett DW, Patten CJ, Dehal SS, Humphreys WG (2005) In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation. Drug Metab Dispos 33: 1729-1739. (Pubitemid 41539973)
-
(2005)
Drug Metabolism and Disposition
, vol.33
, Issue.11
, pp. 1729-1739
-
-
Zhang, D.1
Chando, T.J.2
Everett, D.W.3
Patten, C.J.4
Dehal, S.S.5
Griffith, H.W.6
|